CompositionVolibo 0.3 Tablet is used to manage type 2 diabetes by specifically targeting post-meal (postprandial) blood glucose spikes. It contains Voglibose, an alpha-glucosidase inhibitor that works by delaying the breakdown of complex carbohydrates into simple sugars in the small intestine. This action results in a slower absorption of glucose into the bloodstream, preventing dangerous surges in blood sugar levels after eating.
This tablet should be taken orally before meal. It is an excellent adjunct to diet and exercise, particularly for patients whose fasting glucose is controlled but whose post-meal levels remain high. Inform your doctor if you have a history of inflammatory bowel disease or severe digestive disorders before starting this medication.
